Return to content in this issue

 

JAK inhibition as a therapeutic strategy for IgG4-RD

Khan S1, Gordins P1, Durairaj S2

1Consultant Immunologist, Department of Immunology & Allergy, Castle Hill Hospital, Cottingham, HU16 5JQ, UK
2Consultant Haematologist, Department of Haemato-Oncology, Castle Hill Hospital, Cottingham, HU16 5JQ, UK

J Investig Allergol Clin Immunol 2021; Vol. 31(3)
doi: 10.18176/jiaci.0654

Key words: IgG4-related disease, IgG4-RD, Fibrosis, Cytokines, JAK-Inhibition